[1]孙祝平,陈红英,陈思路.老年阿尔茨海默病患者血清Lp-PLA2，NLRP3 水平表达及其与认知功能损害的相关性[J].现代检验医学杂志,2020,35(01):49-52.[doi:10.3969/j.issn.1671-7414.2020.01.013]
　SUN Zhu-ping,CHEN Hong-ying,CHEN Si-lu.Expression of Serum Lp-PLA2 and NLRP3 in Elderly Patients with Alzheimer's Disease and Its Relationship with Cognitive Impairment[J].Journal of Modern Laboratory Medicine,2020,35(01):49-52.[doi:10.3969/j.issn.1671-7414.2020.01.013]
点击复制

老年阿尔茨海默病患者血清Lp-PLA2，NLRP3 水平表达及其与认知功能损害的相关性 ()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年01期
页码:
49-52
栏目:
论　　著
出版日期:
2020-02-29

文章信息/Info

Title:
Expression of Serum Lp-PLA2 and NLRP3 in Elderly Patients with Alzheimer's Disease and Its Relationship with Cognitive Impairment
文章编号:
1671-7414(2020)01-049-04
作者:
孙祝平; 陈红英; 陈思路
(上海市长宁区精神卫生中心精神科,上海 200335)
Author(s):
SUN Zhu-ping;  CHEN Hong-ying;  CHEN Si-lu
(Department of Psychiatry, Shanghai Changning District Mental Health Center, Shanghai 200335, China)
关键词:
阿尔茨海默病;  脂蛋白相关磷脂酶A2;  NOD样受体家族蛋白3;  认知功能;  相关
分类号:
R749.16; R392.11
DOI:
10.3969/j.issn.1671-7414.2020.01.013
文献标志码:
A
摘要:
目的 分析阿尔茨海默病(AD)患者血清脂蛋白相关磷脂酶A2(lipoprotein related phospholipase, Lp-PLA2),NOD 样受体家族蛋白3(nod-like receptor family protein 3, NLRP3)的表达,及其与认知功能损害的关系。方法 测定110例AD患者(AD组)及50例健康体检者(对照组)血清中Lp-PLA2和NLRP3表达水平,并采用蒙特利尔认知评估量表(MoCA)、简易精神状态量表(MMSE)和临床痴呆量表(CDR)评估患者认知能力。根据CDR评分将AD组患者分为轻度AD组(n=61)和中重度AD组(n=49)。分析各组血清Lp-PLA2和NLRP3表达水平与认知功能损害的相关性。结果 与轻度AD组比较,中重度AD组MoCA和MMSE评分均明显下降,CDR评分明显升高(t=10.21,9.17和7.96,均P<0.05)。与对照组比较,轻度、中重度AD组血清Lp-PLA2,NLRP3水平均明显升高(P<0.05)。与轻度AD组比较,中重度AD组血清Lp-PLA2,NLRP3水平亦显著升高(P<0.05)。Pearson线性相关分析显示,AD患者血清Lp-PLA2,NLRP3水平与MoCA,MMSE评分均呈显著正相关,与CDR评分呈显著负相关(P<0.05)。结论 AD患者血清Lp-PLA2,NLRP3表达异常升高,与认知功能损害密切相关,可作为反映认知功能损害程度的早期血清学标志物。
Abstract:
Objective To investigate the expression of serum lipoprotein related phospholipase A2(Lp-PLA2)and NOD-like receptor family protein 3(NLRP3)in elderly patients with Alzheimer's disease(AD), and analyze its relationship with cognitive impairment. Methods The expression levels of serum Lp-PLA2 and NLRP3 in 110 patients with AD(AD group)and 50 healthy subjects(control group)were measured, and the cognitive ability was evaluated by the Montreal cognitive assessment scale(MoCA), simple mental state scale(MMSE)and clinical dementia scale(CDR). According to the CDR score, patients in the AD group were divided into mild AD group(n=61)and moderate and severe AD group(n=49). The correlation between serum Lp-PLA2 and NLRP3 expression and cognitive impairment was analyzed.Results Compared with the mild AD group, MoCA and MMSE scores in the moderate and severe AD group were significantly decreased, and CDR scores were significantly increased(t=10.21, 9.17 and 7.96, all P<0.05). Compared with the control group, serum Lp-PLA2 and NLRP3 levels in mild, moderate and severe AD groups were significantly increased(P<0.05). Serum Lp-PLA2 and NLRP3 levels were also significantly increased in the moderate to severe AD group compared with the mild AD group(P<0.05). Pearson linear correlation analysis showed that serum Lp-PLA2 and NLRP3 levels were significantly positively correlated with MoCA and MMSE scores and negatively correlated with CDR scores(P<0.05). Conclusion The levels of serum Lp-PLA2 and NLRP3 in patients with AD was overexpressed, which was closely related to cognitive impairment and can be used as early serological markers to reflect the degree of cognitive impairment.

参考文献/References:

[1] HOLZ M R,KOCHHANN R,FERREIRA P,et al. Cognitive performance in patients with Mild Cognitive Impairment and Alzheimer's disease with white matter hyperintensities: an exploratory analysis[J]. Dement Neuropsychol,2017,11(4):426-433.
[2] CUMMINGS J, LEE G, MORTSDORF T, et al. Alzheimer's disease drug development pipeline: 2017[J]. Alzheimers & Dementia Translational Research & Clinical Interventions, 2017, 3(3):367-384.
[3] DANIELS M J, RIVERS-AUTY J, SCHILLING T, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models[J]. Nature Communications, 2016, 7:12504.
[4] GATTAZ W F, TALIB LL, SCHAEFFER E L, et al. Low platelet ip-PLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study[J]. Journal of Neural Transmission, 2014, 121(2):193-200.
[5] American Psychiatric Association. Diagnostic and statistical manual of mental disorders(DSM-VI)[M]. 4th ed. Washington, DC:American Psychiatric Association Publishing, 1994.
[6] LIVINGSTON G, SOMMERLAD A, ORGETA V, et al. Dementia prevention, intervention, and care[J]. Lancet, 2017, 390(10113): 2673-2734.
[7] 许丽春. 阿尔茨海默病患者认知功能障碍的特征及相关危险因素研究[J]. 饮食保健,2016,3(14):39-40. XU Lichun. Study on the characteristics and risk factors of cognitive dysfunction in Alzheimer's patients[J]. Diet Health,2016,3(14):39-40.
[8] KABARIA S, CHOI D C, CHAUDHURI A D,et al. Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson's disease[J].FEBS Letters, 2015,589(3): 319-325.
[9] DOMINGUES C,DA CRUZ E,SILVA OAB, et al. Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks[J]. Curr Alzheimer Res,2017,14(8):870-882.
[10] 高宏娥,李荫桂,黄海云,等.缺血性脑卒中患者血浆脂蛋白相关磷脂酶A2测定的临床意义[J].现代检验医学杂志,2015,30(2): 58-60, 64. GAO Honge,LI Yingui,HUANG Haiyun,et al.Clinical significance of plasma lipoprotein-associated phospholipase A2 detecting in patients with ischemic cerebral stroke[J].Journal of Modern Laboratory Medicine,2015,30(3): 58-60, 64.
[11] 高瑞,易晓淑,晏宁.阿尔茨海默病患者认知功能与自主神经功能关系的研究进展[J].实用心脑肺血管病杂志,2018,26(10):14-17. GAO Rui, YI Xiaoshu, YAN Ning. Progress on relationship between cognitive function and autonomic nervous function in patients with Alzheimer's disease[J].Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease,2018,26(10):14-17.
[12] 郝建华,王田园,张然蓉, 等.阿尔茨海默病患者AD7C-NTP和Aβ42检测的价值探讨[J].现代检验医学杂志,2014,29(1):44-47. HAO Jianhua, WANG Tianyuan, ZHANG Ranrong, et al.Significance of detecting urine AD7C-NTP and blood Aβ42 protein level of Alzheimer patients[J]. Journal of Modern Laboratory Medicine,2014,29(1):44-47.
[13] 尹楠, 岳月红, 邢星, 等. TH、Lp-PLA2、血脂与非痴呆型血管性认知功能障碍的相关性研究[J]. 河北医药, 2015,37(22):3417-3419. YIN Nan, YUE Yuehong, XING xing, et al.Correlation of TH, Lp-PLA2, blood lipid and non - dementia vascular cognitive dysfunction[J]. Hebei Medical Journal, 2015,37(22):3417-3419.
[14] AHMED M E,IYER S,THANGAVEL R,et a1.Co-localization of glia maturation factor with NLRP3 inflammasome and autophagosome markers in human Alzheimer's Disease brain[J]. J Alzheimers Dis Jad,2017,60(3):1143-1160.
[15] 刘俐杰, 柏华. NLRP3炎症小体的活化机制及其在阿尔茨海默病发生发展中的作用[J]. 癫痫与神经电生理学杂志, 2018,27(2):118-121. LIU Lijie, BAI Hua. Activation machanism of NLRP3 inflammasome and its role in the development of Al zheimer's disease.[J]. Journal of Epileptology and Electroneurophysiology(CHINA), 2018,27(2):118-121.
[16] SARESELLA M,LA ROSA F,PIANCONE F,et a1.The NLRP3 and NLRP3 inflammasomes are activated in Alzheimer's disease[J].Molecular Neurodegenerat,2016, 11(1):23.
[17] ROSSOL M,PIERER M,RAULIEN N,et a1.Extracellular Ca2+ is a danger signal activating the NLRP3 imflammasome thorough G protein-coupled calcium sensing receptors[J].Nature Communicat,2012,3:1329.

相似文献/References:

[1]高宏娥,李荫桂,黄海云,等.缺血性脑卒中患者血浆脂蛋白相关磷脂酶A2测定的临床意义[J].现代检验医学杂志,2015,30(02):58.[doi:10.3969/j.issn.1671-7414.2015.02.018]
　GAO Hong-e,LI Yin-gui,HUANG Hai-yun,et al.Clinical Significance of Plasma Lipoprotein-Associated Phospholipase A2 Detecting in Patients with Ischemic Cerebral Stroke[J].Journal of Modern Laboratory Medicine,2015,30(01):58.[doi:10.3969/j.issn.1671-7414.2015.02.018]
[2]张宝华a,武 琪b.Nrf2基因启动子rs35652124,rs6706649和rs6721961位点单核苷酸多态性与阿尔茨海默病的相关性研究[J].现代检验医学杂志,2017,32(05):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
　ZHANG Bao-huaa,WU Qib.Association between Nrf2 Gene rs35652124,rs6706649 and rs6721961 Polymorphism and Alzheimer's Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[3]刘 玥,刘西玲,张 欣,等.Lp-PLA2,Hcy,HbA1c,LDL-C水平与脑微出血相关性研究[J].现代检验医学杂志,2017,32(06):35.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　LIU Yue,LIU Xi-ling,ZHANG Xin,et al.Study on the Relationship between Lipoprotein-Related Phospholipase A2,Homocysteine,Beta-N-1-Deoxy Fructosyl Component of Hemoglobin and Cerebral Microbleeds[J].Journal of Modern Laboratory Medicine,2017,32(01):35.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[4]刘学芳,霍 豆,赵 茜,等.急性脑梗死患者血清VEGF,SAA和Lp-PLA2联合检测的临床研究[J].现代检验医学杂志,2018,33(04):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
　LIU Xue-fang,HUO-Dou,ZHAO-Qian,et al.Diagnostic Value of Combined Detection of VEGF,SAA and Lp-PLA2 for Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2018,33(01):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
[5]刘亚东,冯莉莉,王海晶,等.冠心病患者血清Lp-PLA2与HCY检测及其与冠状动脉病变程度的相关性分析[J].现代检验医学杂志,2018,33(06):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]
　LIU Ya-dong,FENG Li-li,WANG Hai-jing,et al.Detection of Serum Lp-PLA2 and HCY in Patients with Coronary Heart Disease and Its Correlation with the Degree of Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2018,33(01):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]
[6]李婷婷,陈 凤,刘 然.阿尔茨海默病患者血清FGF23 和ZAG 水平表达与认知功能的相关性分析[J].现代检验医学杂志,2023,38(06):166.[doi:10.3969/j.issn.1671-7414.2023.06.030]
　LI Tingting,CHEN Feng,LIU Ran.Correlation Analysis between Serum FGF23 and ZAG Levels and Cognitive Function in Patients with Alzheimer’s Disease[J].Journal of Modern Laboratory Medicine,2023,38(01):166.[doi:10.3969/j.issn.1671-7414.2023.06.030]
[7]刘 倩,边 娜,孙旸园.阿尔茨海默病患者脑脊液SMOC1和OLFML3水平表达及对病情程度的评估价值[J].现代检验医学杂志,2024,39(06):124.[doi:10.3969/j.issn.1671-7414.2024.06.021]
　LIU Qian,BIAN Na,SUN Yangyuan.Expression of SMOC1 and OLFML3 in Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Its Value in Evaluating the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2024,39(01):124.[doi:10.3969/j.issn.1671-7414.2024.06.021]

备注/Memo

备注/Memo:
基金项目:上海市长宁区卫生和计划生育委员会(编号:20163003)。 作者简介:孙祝平(1983-),女,本科,中级,研究方向:精神心理,E-mail:zhuping198306@sina.com。 通讯作者:陈红英(1970-),本科,副高级,研究方向:精神心理,康复,E-mail: xxtchy@139.com。收稿日期:2019-08-02 修回日期:2019-08-30
更新日期/Last Update: 2020-03-30